# A Study of LY3410738 in Healthy Adult Participants

> **NCT06181045** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3410738
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06181045
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-24
- **Primary completion:** 2021-08-04
- **Final completion:** 2021-08-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06181045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06181045, "A Study of LY3410738 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06181045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*